Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital

AUTOR(ES)

Ceglio, William Queiroz Guimarães Wiegandt; Rebeis, Marina Mattos; Santana, Marcela Ferreira; Miyashiro, Denis; Cury-Martins, Jade; Sanches, José Antônio

FONTE

Anais Brasileiros de Dermatologia

DATA DE PUBLICAÇÃO

2022

RESUMO

Abstract Background: Mucocutaneous adverse events are common during anticancer treatment, with variable consequences for the patient and their therapeutic regimen. Objective: To evaluate the most common adverse events, as well as the drugs associated with their appearance and the consequences for cancer treatment. Methods: A retrospective study was carried out through the analysis of patients treated at the Clinical Dermatology Unit of a public oncologic hospital. Results: A total of 138 patients with 200 adverse events were evaluated. The most commonly identified adverse events were nail and periungual changes (20%), papulopustular eruptions (13%), acneiform eruptions (12%), hand-foot syndrome (6.5%), hand-foot skin reaction (6%), and xerosis (6%). The most frequently associated antineoplastic treatment groups were classical chemotherapy (46.2%), target therapy (32.3%), and other non-antineoplastic drugs used in neoplasia protocols (16.5%). Of the total number of patients, 17.4% had their treatment suspended or changed due to a dermatological adverse event. Study limitations: Retrospective study and analysis of patients who were referred for specialized dermatological examination only, not allowing the assessment of the actual incidence of adverse events. Conclusion: A wide variety of dermatological manifestations are secondary to antineoplastic treatment with several different drugs resulting, not rarely, in the interruption or modification of therapeutic regimens.

Documentos Relacionados

• Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
• The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada
• Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital
• Extent, nature and consequences of adverse events: results of a retrospective casenote review in a large NHS hospital
• Ottawa Hospital Patient Safety Study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital